Epidermal growth factor and necrotizing enterocolitis

Current Opinion in Pediatrics

Volumn 24, Issue 2, 2012, Pages

  Coursodon, Christine F ^a   Dvorak, Bohuslav ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

autophagy; epidermal growth factor; necrotizing enterocolitis

Indexed keywords

EPIDERMAL GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 18; MATH1 PROTEIN; MUCIN 2; PLACEBO; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOPHAGY; CONTINUOUS INFUSION; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; HUMAN; LIVER FUNCTION; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TIGHT JUNCTION;

ANIMALS; APOPTOSIS; AUTOPHAGY; BIOLOGICAL MARKERS; ENTEROCOLITIS, NECROTIZING; EPIDERMAL GROWTH FACTOR; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LIVER;

EID: 84859103422     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283504ddb     Document Type: Review

References (55)

1. Israel EJ. Neonatal necrotizing enterocolitis, adisease of the immature intestinal mucosal barrier. Acta Paediatr Suppl 1994; 396:27-32. (Pubitemid 24186056)
2. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255-264.
3. Nair RR, Warner BB, Warner BW. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol 2008; 32:107-113. (Pubitemid 351381169)
4. Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs 2008; 68:1227-1238. (Pubitemid 351822112)
5. Frost BL, Caplan MS. Probiotics and prevention of neonatal necrotizing enterocolitis. Curr Opin Pediatr 2011; 23:151-155.
6. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979; 48:193-216. (Pubitemid 10191090)
7. Playford RJ, Wright NA. Why isepidermal growth factor present in the gut lumen? Gut 1996; 38:303-305. (Pubitemid 26075531)
8. Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res 2003; 284:2-13. (Pubitemid 36331964)
9. Guo J, Sheng G, Warner BW. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J Biol Chem 2005; 280:35992-35998. (Pubitemid 41633868)
10. Chailler P, Menard D. Ontogeny of eGF receptors in the human gut. Front Biosci 1999; 4:D87-D101.
11. Sullivan PB, Brueton MJ, Tabara ZB, et al. Epidermal growth factor in necrotising enteritis. Lancet 1991; 338:53-54.
12. Sullivan PB, Lewindon PJ, Cheng C, et al. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg 2007; 42:462-469. This small clinical study demonstrates that EGF treatment of NEC is well tolerated and produces measurable trophic effect on the gastrointestinal tract. (Pubitemid 46335706)
13. Scott SM, Rogers C, Angelus P, et al. Effect of necrotizing enterocolitis on urinary epidermal growth factor levels. Am J Dis Child 1991; 145:804-807.
14. Shin CE, Falcone RA Jr, Stuart L, et al. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis. J Pediatr Surg 2000; 35:173-176.
15. Helmrath MA, Shin CE, Fox JW, et al. Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis. Lancet 1998; 351:266-267. (Pubitemid 28043958)
16. Warner BB, Ryan AL, Seeger K, et al. Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr 2007; 150:358-363. This study provides information about salivary EGF levels and risk to develop neonatal NEC in premature babies. (Pubitemid 46437327)
17. Carpenter G. Epidermal growth factor isa major growth-promoting agent in human milk. Science 1980; 210:198-199. (Pubitemid 11252461)
18. Connolly JM, Rose DP. Epidermal growth factor-like proteins in breast fluid and human milk. Life Sci 1988; 42:1751-1756.
19. Moran JR, Courtney ME, Orth DN, et al. Epidermal growth factor in human milk: daily production and diurnal variation during early lactation in mothers delivering at term and at premature gestation. J Pediatr 1983; 103:402-405. (Pubitemid 13000455)
20. Okada M, Ohmura E, Kamiya Y, et al. Transforming growth factor (TGF)-alpha in human milk. Life Sci 1991; 48:1151-1156.
21. Miettinen PJ, Berger JE, Meneses J, et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995; 376:337-341.
22. Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002; 282:G156-G164. (Pubitemid 34650110)
23. Kanai T, Watanabe M, Okazawa A, et al. Interleukin-18 and Crohn's disease. Digestion 2001; 63:37-42. (Pubitemid 32098439)
24. Halpern MD, Holubec H, Dominguez JA, et al. Up-regulation of iL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 2002; 51:733-739. (Pubitemid 34547337)
25. Halpern MD, Dominguez JA, Dvorakova K, et al. Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor. J Pediatr Gastroenterol Nutr 2003; 36:126-133. (Pubitemid 41672632)
26. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-274. (Pubitemid 23320290)
27. Rouwet EV, Heineman E, Buurman WA, et al. Intestinal permeability and carrier-mediated monosaccharide absorption in preterm neonates during the early postnatal period. Pediatr Res 2002; 51:64-70. (Pubitemid 34008211)
28. Clark JA, Doelle SM, Halpern MD, et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 2006; 291:G938-G949. (Pubitemid 44772020)
29. Specian RD, Oliver MG. Functional biology of intestinal goblet cells. Am J Physiol 1991; 260:C183-C193.
30. Einerhand AW, Renes IB, Makkink MK, et al. Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J Gastroenterol Hepatol 2002; 14:757-765. (Pubitemid 34753960)
31. Fanning AS, Mitic LL, Anderson JM. Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 1999; 10:1337-1345. (Pubitemid 29247001)
32. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001; 120:411-422. (Pubitemid 32147639)
33. Jilling T, Lu J, Jackson M, et al. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 2004; 55:622-629. (Pubitemid 38405849)
34. Kerr JF, Wyllie AH, Currie AR. Apoptosis: abasic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
35. Clark JA, Lane RH, Maclennan NK, et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005; 288:G755-G762. (Pubitemid 40388187)
36. Knott AW, Juno RJ, Jarboe MD, et al. EGF receptor signaling affects bcl-2 family gene expression and apoptosis after massive small bowel resection. J Pediatr Surg 2003; 38:875-880. (Pubitemid 36666281)
37. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42.
38. Gutierrez MG, Saka HA, Chinen I, et al. Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc Natl Acad Sci U S A 2007; 104:1829-1834. (Pubitemid 46239864)
39. Maynard AA, Dvorak K, Khailova L, et al. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010; 299:G614-G622. This recent study introduces a novel mechanism by which EGF downregulates epithelial cell death and protects the intestinal epithelium against mucosal injury.
40. Suzuki K, Ohsumi Y. Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett 2007; 581:2156-2161. (Pubitemid 46709906)
41. Wu J, Dang Y, Su W, et al. Molecular cloning and characterization of rat LC3A and LC3B: two novel markers of autophagosome. Biochem Biophys Res Commun 2006; 339:437-442. (Pubitemid 41697567)
42. Morecroft JA, Spitz L, Hamilton PA, et al. Necrotizing enterocolitis: multisystem organ failure of the newborn? Acta Paediatr Suppl 1994; 396:21-23. (Pubitemid 24186054)
43. Moss RL, Das JB, Raffensperger JG. Necrotizing enterocolitis and total parenteral nutrition-associated cholestasis. Nutrition 1996; 12:340-343. (Pubitemid 26294995)
44. Halpern MD, Holubec H, Clark JA, et al. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis. Biol Neonate 2006; 89:227-235. (Pubitemid 43886934)
45. Khailova L, Dvorak K, Arganbright KM, et al. Changes in hepatic cell junctions structure during experimental necrotizing enterocolitis: effect of EGF treatment. Pediatr Res 2009; 66:140-214.
46. Tsukita S, Furuse M, Itoh M. Multifunctional strands intight junctions. Nat Rev Mol Cell Biol 2001; 2:285-293.
47. Lee JI, Kim KS, Oh BC, Kim NA, et al. Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta). J Med Primatol 2011; 40:188-193.
48. Luo CC, Ming YC, Chao HC, Chu SM, et al. Heparin-Binding Epidermal Growth Factor-Like Growth Factor Downregulates Expression of Activator Protein-1 Transcription Factor after Intestinal Ischemia-Reperfusion Injury. Neonatology 2011; 99:241-246.
49. Maynard AA, Dvorak K, Khailova L, et al. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010; 299:G614-G622. [39]
50. Siggers RH, Siggers J, Thymann T, Boye M, et al. Nutritional modulation of the gut microbiota and immune system in preterm neonates susceptible to necrotizing enterocolitis [Review]. J Nutr Biochem 2011; 22:511-521.
51. Sullivan PB, Lewindon PJ, Cheng C, et al. Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis. J Pediatr Surg 2007; 42:462-469. [12] (Pubitemid 46335706)
52. Tremblay E, Ferretti E, Babakissa C, Seidman EG, et al. Gene-expression Profile Analysis in the Mid-gestation Human Intestine Discloses Greater Functional Immaturity of the Colon as Compared With the Ileum. J Pediatr Gastroenterol Nutr 2011; 52:670-678.
53. Warner BB, Ryan AL, Seeger K, et al. Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr 2007; 150:358-363. [16] (Pubitemid 46437327)
54. Xu JL, Treem WR, Roman C, Anderson V, et al. Ileal Immune Dysregulation in Necrotizing Enterocolitis: Role of CD40/ CD40L in the Pathogenesis of Disease. J Pediatr Gastroenterol Nutr 2011; 52:140-146.
55. Zhang HY, Radulescu A, Chen CL, Olson JK, et al. Mice overexpressing the gene for heparin-binding epidermal growth factor-like growth factor (HB-EGF) have increased resistance to hemorrhagic shock and resuscitation. Surgery 2011; 149:276-283.